Target intelligence / Profile preview

Thrombus (Cerebral Arteries)

Molecular classification
Other, Pathological aggregate
01

Overview

A thrombus in the cerebral arteries refers to a pathological blood clot that forms within or embolizes to the arterial supply of the brain, leading to acute ischemic stroke [1]. It is not a single molecular target but a complex biological structure composed of a fibrin meshwork, activated platelets, and trapped red and white blood cells [4]. The formation of such a thrombus obstructs cerebral blood flow, resulting in oxygen deprivation and rapid neuronal death in the affected territory [2]. In clinical practice, the thrombus is the primary focus of acute intervention, where thrombolytic drugs like Alteplase are used to chemically dissolve the fibrin structure [3]. Additionally, mechanical thrombectomy may be employed to physically retrieve the thrombus from the vessel. Prevention of thrombus recurrence involves pharmacological targeting of the coagulation cascade and platelet function using anticoagulants and antiplatelets [1].

Other names
Blood clotCerebral blood clotIntracranial thrombusCerebral embolusIntravascular coagulation
02

Mechanism of action

Thrombolytic agents (plasminogen activators) bind to fibrin within the thrombus and convert entrapped plasminogen to plasmin, which enzymatically degrades the fibrin matrix to dissolve the clot [1]. Antiplatelet agents inhibit specific enzymes (e.g., COX-1) or receptors (e.g., P2Y12) to prevent platelet activation and aggregation [3]. Anticoagulants interfere with the coagulation cascade (e.g., inhibiting Factor Xa or Thrombin) to prevent the formation and propagation of fibrin strands [4].

03

Biological functions

HemostasisVascular occlusionFibrin polymerization
04

Disease associations

Ischemic strokeCerebrovascular diseaseTransient ischemic attack (TIA)Cerebral venous sinus thrombosis
05

Safety considerations

Intracranial hemorrhageHemorrhagic transformation of ischemic infarctSystemic bleedingOrolingual angioedema (associated with tPA)Reperfusion injury
06

Interacting drugs

Alteplase

10 more in the full profile.

07

Biomarkers

D-dimerHyperdense cerebral artery sign (CT imaging)NIH Stroke Scale (NIHSS) scoreComputed Tomography Angiography (CTA) filling defectDiffusion-weighted imaging (DWI) lesions

Beyond the preview

Go deeper on Thrombus (Cerebral Arteries).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thrombus (Cerebral Arteries).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call